Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 981 | 1223 | 1057 | 1336 | 1944 |
Fund Return | 6.3% | -1.91% | 22.31% | 1.86% | 5.97% | 6.87% |
Place in category | 512 | 561 | 352 | 275 | 334 | 20 |
% in Category | 73 | 82 | 54 | 49 | 55 | 7 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VALIC Company I Stock Index | 6.91B | 20.68 | 8.74 | 12.64 | ||
VALIC Company I Mid Cap Index | 2.95B | 12.41 | 4.80 | 9.50 | ||
VALIC Company I Science & Technolog | 2.9B | 24.29 | 4.99 | 16.86 | ||
VALIC Company I International Eqs I | 1.78B | 6.32 | 2.18 | 4.77 | ||
VALIC Company I Growth | 1.77B | 24.14 | 5.23 | 13.93 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 204.36B | 8.15 | 1.40 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 75.61B | 8.18 | 1.45 | 4.94 | ||
Fidelity International Index Inst | 52.9B | 6.96 | 2.81 | 5.35 | ||
Fidelity Series Global ex US Index | 48.18B | 8.52 | 1.64 | 4.77 | ||
Strategic Advisers International I | 42.32B | 8.45 | 1.91 | 6.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Msci Eafe Dec24 Ifus 20241220 | - | 2.33 | - | - | |
Novo Nordisk B | DK0062498333 | 2.32 | 750.9 | +4.03% | |
ASML Holding | NL0010273215 | 2.17 | 642.10 | +1.68% | |
SAP | DE0007164600 | 1.69 | 225.900 | +0.53% | |
AstraZeneca | GB0009895292 | 1.41 | 10,474.0 | +4.09% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review